Investor Relations

Webcast

Register to Listen to Q1 2015 Financial Results Call

Register Now

Latest Financial Results

Symbol

NASDAQ: AXGN

Price

Loading...

Change

Loading...

Shares Oustanding

24926014

MKT Cap

Loading...

Volume

Loading...

AxoGen is a leading medical technology company dedicated to peripheral nerve repair. AxoGen's portfolio of regenerative medicine products is available in the United States, Canada and several other countries, and includes Avance® Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with an additional surgical site, AxoGuard® Nerve Connector, a porcine submucosa extracellular matrix ("ECM") coaptation aid for tensionless repair of severed nerves, and AxoGuard® Nerve Protector, a porcine submucosa ECM product used to wrap and protect injured peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments.